TRAIL selectively kills cancer cells without harming most normal cells. However, TRAIL resistance is a major problem for its therapeutic use. Developing a strategy to overcome resistance is crucial for the successful use of TRAIL as an antitumor agent. In our screening program of natural products that can abrogate TRAIL resistance, four germacranolides (1-4) were isolated from the aerial parts of Enhydra fluctuans. All compounds exhibited potent TRAILresistance overcoming activity against TRAIL-resistant human gastric adenocarcinoma (AGS) cells.
Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) can induce apoptosis in a variety of cancer cells while sparing normal cells, and thus makes it a promising anticancer agent [1] . TRAIL is now under preclinical investigation due to its strength to induce significant tumor inhibition in experimental animals without producing systemic toxicity. However, some cancer cells are said to be resistant to TRAIL-induced apoptosis [2] . Binding of TRAIL with death receptors (DR5) and/or DR4 persuades the formation of the death-inducing signaling complex (DISC), which activates caspase-signaling pathways, leading to cell necrosis (an extrinsic or death-receptor pathway). In the mitochondrial (intrinsic) pathway, the proapoptotic Bcl-2 family members, Bak and Bax, form orifices in the mitochondrial outer membrane, and activate caspase-9, which causes cell death [1a,b] . TRAIL-resistance may appear at different positions in the TRAIL-mediated apoptotic pathways. To find out the mechanisms of TRAIL-resistance and design strategies to abrogate such resistance are crucial for its successful therapeutic use [2, 3] . The search for agents that can overcome TRAILresistance may be an important action plan for the development of effective antitumor lead compounds. Some natural compounds can overcome TRAIL-resistance activity. Luteolin, a naturally occurring flavone derivative, leads to cell death in various cancer cells [4] .
Previous studies reported that some natural compounds such as curcumin, resveratrol, indole-3-carbinol, xanthinosin, and 6β-acetoxysandaracopimaradiene-1α,9α-diol reinforced TRAILinduced necrosis in malignant cells [1a,5,6a] . During our present research program for separation of active compounds that can abrogate TRAIL-resistance, we investigated the antiproliferative activity of medicinal resources of Bangladesh. After primary checking of activity, we found that the MeOH extract of aerial parts of Enhydra fluctuans Lour. The separated compounds (1-4) were examined for their TRAILresistance overcoming activity in human gastric adenocarcinoma (AGS) cells. Treatment of AGS cells with TRAIL (100 ng/mL) for 24 h exhibited a little decline in cell viability (92%) (Figure 2) . Luteolin, used as a positive control, at 17.5 µM, showed about 63% difference in viability between TRAIL and without TRAIL. Treatment of cells with 0.1, 0.25 and 0.5 µM of 1 and 3, along with TRAIL (100 ng/mL), showed strong TRAIL-resistance overcoming activity. However, the highest inhibition was found at 0.25 µM, which resulted in about 33 and 31% more inhibition, respectively, than the agents alone; 2 and 4 exhibited potent TRAIL-resistance overcoming activity at 0.25, 0.5 and 1.0 µM. Treatment of AGS cells with 100 ng/mL TRAIL and 0.5 µM of both 2 and 4 exhibited about 28 and 31% more inhibition, respectively, than the agents alone ( Figure 2 ).
Germacranolides, a subclass of sesquiterpene lactones, constitute a large and diverse group of bioactive compounds that induce apoptosis through the intrinsic pathway, and sensitization of the extrinsic pathway [7e]. Germacranolides were previously reported to show cytotoxic activity against human hepatoma (SMMC-7721), promyelocytic leukemia (HL-60), and hepatocyte (L02) cell lines [7f]. However, so far as we know, this is the first report on their ability to abrogate TRAIL-resistance.
On the basis of the present study, activity guided fractionation of E. fluctuans led to the separation of four germacranolides, fluctuadin (1), enhydrin (2), fluctuanin (3), and chloroenhydrin (4). All showed potent activity for abrogating TRAIL-resistance in TRAILresistant AGS cells.
Experimental
General: NMR, JEOL ECZ600 and ECA600 NMR spectrometers; Optical rotations, JASCO P-1020 polarimeter; ESIMS, JEOL JMS-T100LP mass spectrometer; CC, silica gel 60N and Chromatorex ODS; Preparative HPLC was operated using YMC-pack Pro C 18 (YMC Co. Ltd., Kyoto, Japan). Protein concentrations were recorded with a Nano Drop 2000 spectrophotometer (Thermo), and Western blotting membranes were analyzed by a Bio-Rad (ChemiDoc XRS+) instrument. A Fluoroskan Ascent instrument (Thermo Fisher Scientific, Waltham, MA, USA) was used to measure fluorescence.
Plant material: Aerial parts of Enhydra fluctuans were collected from the district of Bagerhat, Bangladesh in December, 2013. A voucher specimen (KKB 371) is preserved at the Laboratory of Natural Products Chemistry, Chiba University, Japan.
Extraction and isolation:
The air-dried aerial parts (122 g) of E. fluctuans were extracted using MeOH. The crude extract (21.5 g) was passed through a Diaion HP-20 column using MeOH-acetone to afford the chlorophyll-free fraction 1A (16.4 g). This was partitioned between n-hexane, EtOAc, and n-BuOH (400 mL × 3) to obtain dried n-hexane (472 mg), EtOAc (3.0 g), n-BuOH (4.4 g), and water (8.4 g) fractions. The n-hexane fraction (472 mg) was fractionated using Silica gel 60N column chromatography (φ 40 × 420 mm) eluted with CHCl 3 /MeOH (7:1 → 0:1) to afford fractions 2A to 2Q. Fraction 2M (21 mg) and 2N (39 mg) were crystallized in EtOH to obtain compounds 1 (6 mg) and 2 (2.7 mg). Fraction 2L was subjected to ODS flash column chromatography [φ 15 × 650 mm, MeOH/H 2 O (1:1 → 3:1)] to obtain fractions 5A-5W. From fraction 3I compound 3 was isolated. Fraction 2N (42 mg) was subjected to ODS column chromatography (φ 15 × 650 mm) eluted with MeOH/H 2 O (1:1 → 3:1 to produce fractions 4A-4O. From fractions 4B and 4C (11 mg), compound 4 was isolated after performing YMC-pack Pro C 18 HPLC (φ 10 × 250 mm, 55% MeOH).
Cell cultures: AGS cells originated from the Institute of Development, Aging and Cancer, Tohoku University; Cells were cultured in RPMI-1640 medium (Wako) with 10% FBS. Cultures were maintained in a humidified incubator at 37°C in 5% CO 2 /95% air.
Viability assay (FMCA): AGS cells were cultured in Roswell Park
Memorial Institute (RPMI)-1640 medium (Wako, Osaka, Japan) with 10% FBS (fetal bovine serum) and 1% penicillin-streptomycin. A humidifier incubator (37°C in 5% CO 2 /95% air) was used to maintain cell culture. Fluorometric microculture cytotoxicity assay (FMCA) was used to assess cell viability in the presence and absence of TRAIL using TRAIL-resistant AGS cells. 200 µL of medium containing 10% FBS was used to seed cells in a 96-well culture plate (6 x 10 3 cells per well). Cells were then incubated at 37°C in a 5% CO 2 incubator for 24 h. Different concentrations of test samples with or without TRAIL (100 ng/mL) were added to each well. After 24 h incubation, the cells were washed with PBS, and 200 µL of PBS containing fluorescein diacetate (10 µg/mL) was added to each well [8] . The plates were incubated at 37°C for 1 h, and Fluoroskan Ascent (Thermo Fisher Scientific, Waltham, MA, USA) was used to measure fluorescence at 538 nm with excitation at 485 nm. Luteolin (purity ≥ 98%, Sigma-Aldrich) was used as a positive control.
